Dr. Reddys Laboratories Ltd.

Dr. Reddy's Laboratories has received the Establishment Inspection Report (EIR) from US Food and Drug Administration (USFDA) for API manufacturing plant at Miryalaguda (Nalgonda District) indicating closure of the audit and the inspection classification of this facility is determined as Voluntary Action Initiated (VAI). Earlier, USFDA had conducted audit at Miryalaguda plant on January 28, 2019.

Dr. Reddy's Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.